Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1K23AA031334-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hepatology Clinicians | Experimental | Clinician participants will participate in a multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested. Participants will attend two approximately 60-minute-long educational sessions in which key points related to AUD treatment based on the HPCR resource and implementation facilitation intervention will be reviewed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Implementation Intervention | Behavioral | A multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility | Percentage of clinicians enrolled out of all recruited | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability | Percentage of clinicians that attend the educational workshops and utilize implementation tools. | 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lamia Haque, MD MPH | Contact | (203) 777-0304 | lamia.haque@yale.edu |
| Name | Affiliation | Role |
|---|---|---|
| Lamia Haque | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yale School of Medicine/Yale-New Haven Health | Recruiting | New Haven | Connecticut | 06520 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Hepatology clinicians including attending physicians, trainees, and advanced practice providers will be invited to participate in an implementation facilitation intervention to improve AUD treatment in hepatology clinics. The interventions will include education, patient materials, clinical decision support tools and coaching/feedback.
Not provided
Not provided
Not provided
Not provided